Rein Therapeutics Inc. ( RNTX) - Stock Earnings
RNTX Upcoming earnings
Estimated EPS and revenue columns are available to paid members.
| Date | EPS (actual / est.) | Revenue low (est.) | Revenue (actual / est.) | Revenue high (est.) |
|---|---|---|---|---|
| Aug. 13, 2026, midnight | — / — | — | — / — | — |
RNTX Quarterly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2025Q3 | -5.6 million USD | — USD |
| 2025Q4 | -32.0 million USD | — USD |
| 2026Q1 | -5.8 million USD | — USD |
| 2026Q3 Est. | — | — |
| 2026Q4 Est. | — | — |
RNTX Yearly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | -15732 USD | — USD |
| 2024 | -62.9 million USD | — USD |
| 2025 | -49.9 million USD | — USD |
| 2026 Est. | — | — |
RNTX
Price: $0.79
52 week price:
Earnings Per Share: -1.90 USD
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Market Capitalization: 27.7 million